Two Gibson Dunn Deals Named Impact Deals of the Year at the LMG Life Sciences Awards EMEA 2023
Accolades | July 20, 2023
LMG Life Sciences
Quidel’s merger with Ortho Clinical Diagnostics and GE HealthCare Technologies’ spinoff were named among the Impact Deals of the Year at the LMG Life Sciences Awards EMEA 2023. Gibson Dunn advised Quidel and was among the teams advising GE HealthCare Technologies on these deals. The awards were announced on July 13, 2023.
The Life Sciences Practice Group represents and advises innovative biotechnology, pharmaceutical and medical device companies on a wide range of legal, regulatory and strategic issues, including patent and product liability litigation, U.S. Food and Drug Administration (FDA) investigations and enforcement actions, and corporate transactions and financings. Many Gibson Dunn lawyers hold advanced scientific degrees and have hands-on experience working in life sciences companies or within the government agencies that regulate the industry.